HUT60626A - Process for producing pharmaceutical compositions comprising rapamycin and inhibiting development of insulin-dependent diabetes - Google Patents

Process for producing pharmaceutical compositions comprising rapamycin and inhibiting development of insulin-dependent diabetes

Info

Publication number
HUT60626A
HUT60626A HU9201113A HU9201113A HUT60626A HU T60626 A HUT60626 A HU T60626A HU 9201113 A HU9201113 A HU 9201113A HU 9201113 A HU9201113 A HU 9201113A HU T60626 A HUT60626 A HU T60626A
Authority
HU
Hungary
Prior art keywords
insulin
rapamycin
dependent diabetes
pharmaceutical compositions
producing pharmaceutical
Prior art date
Application number
HU9201113A
Other languages
English (en)
Other versions
HU9201113D0 (en
Inventor
William Lee Baeder
Surendra Nath Sehgal
Laurel Moore Adams
Thomas Joseph Caggiano
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/792,105 external-priority patent/US5321009A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of HU9201113D0 publication Critical patent/HU9201113D0/hu
Publication of HUT60626A publication Critical patent/HUT60626A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
HU9201113A 1991-04-03 1992-04-02 Process for producing pharmaceutical compositions comprising rapamycin and inhibiting development of insulin-dependent diabetes HUT60626A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67970691A 1991-04-03 1991-04-03
US07/792,105 US5321009A (en) 1991-04-03 1991-11-14 Method of treating diabetes

Publications (2)

Publication Number Publication Date
HU9201113D0 HU9201113D0 (en) 1992-06-29
HUT60626A true HUT60626A (en) 1992-10-28

Family

ID=27102296

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9201113A HUT60626A (en) 1991-04-03 1992-04-02 Process for producing pharmaceutical compositions comprising rapamycin and inhibiting development of insulin-dependent diabetes

Country Status (19)

Country Link
EP (1) EP0507555B1 (hu)
JP (1) JP2535119B2 (hu)
AT (1) ATE139120T1 (hu)
AU (1) AU652037B2 (hu)
CA (1) CA2064678A1 (hu)
CZ (1) CZ282733B6 (hu)
DE (1) DE69211406T2 (hu)
DK (1) DK0507555T3 (hu)
ES (1) ES2089395T3 (hu)
GR (1) GR3020316T3 (hu)
HK (1) HK108797A (hu)
HU (1) HUT60626A (hu)
IE (1) IE74884B1 (hu)
IL (1) IL101353A0 (hu)
MX (1) MX9201513A (hu)
NO (1) NO921279L (hu)
NZ (1) NZ242190A (hu)
SG (1) SG43075A1 (hu)
SK (1) SK279180B6 (hu)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378696A (en) * 1990-09-19 1995-01-03 American Home Products Corporation Rapamycin esters
US5177203A (en) * 1992-03-05 1993-01-05 American Home Products Corporation Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
US5256790A (en) * 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
CA2106034A1 (en) * 1992-09-24 1994-03-25 Ralph J. Russo 21-norrapamycin
US5480989A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5302584A (en) * 1992-10-13 1994-04-12 American Home Products Corporation Carbamates of rapamycin
US5480988A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5434260A (en) * 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
US5489680A (en) * 1992-10-13 1996-02-06 American Home Products Corporation Carbamates of rapamycin
US5349060A (en) * 1993-01-07 1994-09-20 American Home Products Corporation Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents
US5252579A (en) * 1993-02-16 1993-10-12 American Home Products Corporation Macrocyclic immunomodulators
US7279561B1 (en) 1993-04-23 2007-10-09 Wyeth Anti-rapamycin monoclonal antibodies
ES2295093T3 (es) 1993-04-23 2008-04-16 Wyeth Conjugados y anticuerpos de rapamicina.
US5504091A (en) * 1993-04-23 1996-04-02 American Home Products Corporation Biotin esters of rapamycin
US5387680A (en) * 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
US5391730A (en) * 1993-10-08 1995-02-21 American Home Products Corporation Phosphorylcarbamates of rapamycin and oxime derivatives thereof
US5373014A (en) * 1993-10-08 1994-12-13 American Home Products Corporation Rapamycin oximes
US5378836A (en) * 1993-10-08 1995-01-03 American Home Products Corporation Rapamycin oximes and hydrazones
US5385908A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
US5385909A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Heterocyclic esters of rapamycin
US5385910A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Gem-distributed esters of rapamycin
US5389639A (en) * 1993-12-29 1995-02-14 American Home Products Company Amino alkanoic esters of rapamycin
US5525610A (en) * 1994-03-31 1996-06-11 American Home Products Corporation 42-Epi-rapamycin and pharmaceutical compositions thereof
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5496831A (en) * 1994-05-13 1996-03-05 The General Hospital Corporation Inhibition of insulin-induced adiposis
US5463048A (en) * 1994-06-14 1995-10-31 American Home Products Corporation Rapamycin amidino carbamates
US5491231A (en) * 1994-11-28 1996-02-13 American Home Products Corporation Hindered N-oxide esters of rapamycin
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
US5561138A (en) * 1994-12-13 1996-10-01 American Home Products Corporation Method of treating anemia
US5496832A (en) * 1995-03-09 1996-03-05 American Home Products Corporation Method of treating cardiac inflammatory disease
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
TW427904B (en) * 1995-12-07 2001-04-01 American Home Prod Neuroprotective agents
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
US5922730A (en) * 1996-09-09 1999-07-13 American Home Products Corporation Alkylated rapamycin derivatives
US6015809A (en) * 1998-08-17 2000-01-18 American Home Products Corporation Photocyclized rapamycin
IL154925A0 (en) * 2000-09-14 2003-10-31 Beth Israel Hospital Modulation of il-2 and il-15-mediated t cell responses
DE60329724D1 (de) 2002-06-07 2009-11-26 Waratah Pharmaceuticals Inc Methoden und Kompositionen um Diabetes zu behandeln

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5023263A (en) * 1990-08-09 1991-06-11 American Home Products Corporation 42-oxorapamycin

Also Published As

Publication number Publication date
EP0507555A1 (en) 1992-10-07
HK108797A (en) 1997-08-22
ES2089395T3 (es) 1996-10-01
HU9201113D0 (en) 1992-06-29
NO921279L (no) 1992-10-05
NO921279D0 (no) 1992-04-02
SK279180B6 (sk) 1998-07-08
ATE139120T1 (de) 1996-06-15
JP2535119B2 (ja) 1996-09-18
DE69211406D1 (de) 1996-07-18
IE74884B1 (en) 1997-08-13
AU1395792A (en) 1992-10-08
NZ242190A (en) 1997-06-24
GR3020316T3 (en) 1996-09-30
MX9201513A (es) 1993-04-01
CZ97292A3 (en) 1993-09-15
EP0507555B1 (en) 1996-06-12
AU652037B2 (en) 1994-08-11
IL101353A0 (en) 1992-11-15
DK0507555T3 (da) 1996-07-01
DE69211406T2 (de) 1996-11-28
IE921055A1 (en) 1992-10-07
CA2064678A1 (en) 1992-10-04
JPH0597688A (ja) 1993-04-20
CZ282733B6 (cs) 1997-09-17
SK97292A3 (en) 1994-11-09
SG43075A1 (en) 1997-10-17

Similar Documents

Publication Publication Date Title
HUT60626A (en) Process for producing pharmaceutical compositions comprising rapamycin and inhibiting development of insulin-dependent diabetes
EP0618818A4 (en) SAFETY SYRINGE.
HU0800468D0 (en) Medicament for inhalation, canister and device containing the same
HU9400350D0 (en) Retard peptides
ZA914830B (en) Novel,protracted insulin analogues
AU4714393A (en) Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
EP0841961A4 (en) SAFETY SYRINGE
GR3018890T3 (en) Medicament dispensing device.
AU1330392A (en) Safety syringe
AU8435891A (en) Safety locking device
EP0601077A4 (en) Medical syringe with needle-retracting mechanism.
GB2223168B (en) Pharmaceutical composition comprising inositoltrisphosphate for the treatment of complications of diabetes
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
KR0166663B1 (en) Use of il-10 to prevent insulin-dependent diabetes mellitus
ZA927028B (en) Safety syringe.
GB2245914B (en) Orifice well safety valve with release mechanism
EP0501889A3 (en) Anti-epileptic composition containing striripentol associated with an anti-epileptic drug
EP0646384A3 (en) Safety syringe.
GR3002305T3 (en) Fungicidal mixtures with prochloraz
IL111361A0 (en) Pharmaceutical compositions for the treatment of insulin dependent diabetes mellitus (iddm)
CA67045S (en) Games accessory for use with marbles, counters or the like
AR243771A1 (es) Jeringas hipodermicas autodescartables
GB9122766D0 (en) Medicament composition
GB9107910D0 (en) Safety syringe
GB9103589D0 (en) Safety syringe

Legal Events

Date Code Title Description
DFC9 Refusal of application